Evidence map›Paper›PMID 16951081›Full record

ArticleGenetics2006

Mutator phenotype of Caenorhabditis elegans DNA damage checkpoint mutants.

Jasper Harris, Mia Lowden, Iuval Clejan, Monika Tzoneva, James H Thomas, Jonathan Hodgkin, Shawn Ahmed

Abstract read
In one paragraph

Article in Genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Caenorhabditis elegans RSD-2 and RSD-6 promote germ cell immortality by maintaining small interfering RNA populations.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cancer models in Caenorhabditis elegans.Developmental dynamics : an official publication of the American Association of Anatomists · 2010
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jasper HarrisDepartment of Biology, University of North Carolina, NC 27599-3280, USA.
Mia Lowden
Iuval Clejan
Monika Tzoneva
James H Thomas
Jonathan Hodgkin
Shawn Ahmed

Funding

Genetics of Telomerase in C. elegansR01GM066228 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AHMED, SHAWN CAMERON · 2002 to 2016
$4.0M
Genetics of Telomerase in C. elegansR56GM066228 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AHMED, SHAWN CAMERON · 2008 to 2008
$302k
Medical Research Council G0000114NIGMS NIH HHS GM066228NIGMS NIH HHS R01 GM066228NIGMS NIH HHS R56 GM066228
6 · The paper itself

Abstract

DNA damage response proteins identify sites of DNA damage and signal to downstream effectors that orchestrate either apoptosis or arrest of the cell cycle and DNA repair. The C. elegans DNA damage response mutants mrt-2, hus-1, and clk-2(mn159) displayed 8- to 15-fold increases in the frequency of spontaneous mutation in their germlines. Many of these mutations were small- to medium-sized deletions, some of which had unusual sequences at their breakpoints such as purine-rich tracts or direct or inverted repeats. Although DNA-damage-induced apoptosis is abrogated in the mrt-2, hus-1, and clk-2 mutant backgrounds, lack of the apoptotic branch of the DNA damage response pathway in cep-1/p53, ced-3, and ced-4 mutants did not result in a Mutator phenotype. Thus, DNA damage checkpoint proteins suppress the frequency of mutation by ensuring that spontaneous DNA damage is accurately repaired in C. elegans germ cells. Although DNA damage response defects that predispose humans to cancer are known to result in large-scale chromosome aberrations, our results suggest that small- to medium-sized deletions may also play roles in the development of cancer.

Indexed as

Genes, cdcPhenotypeSequence DeletionAnimalsBase SequenceCaenorhabditis elegansCaenorhabditis elegans ProteinsDNA DamageDNA RepairMolecular Sequence DataTelomere-Binding ProteinsCaenorhabditis elegans Proteinsclk-2 protein, C elegansMRT-2 protein, C elegansTelomere-Binding Proteins

Identifiers

PMID16951081
PMCPMC1602097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.